JNJ vs ULTY: Dividend Yield, Growth & Safety Comparison
Johnson & Johnson (JNJ) from Health Care and YieldMax Ultra Option Income Strategy ETF (ULTY) from N/A offer different dividend profiles for income-focused portfolios. ULTY offers a significantly higher 137.83% yield compared to JNJ's 2.16%, a gap of 135.67%. For dividend growth, JNJ leads with a 5-year CAGR of 5.2% versus ULTY's -88.4%. JNJ is a Dividend King with 63 years of consecutive increases.
Key Metrics Comparison
| Metric | JNJ | ULTY |
|---|
| Dividend Yield | 2.16% | 137.83% |
| Annual Dividend | $5.14 | $45.23 |
| 5-Year CAGR | 5.2% | -88.4% |
| Payout Ratio | 47% | N/A |
| Consecutive Years | 63 | 0 |
| Price | $243.53 | $34.47 |
Yield Comparison
YieldMax Ultra Option Income Strategy ETF (ULTY) currently yields 137.83%, which is high for the broader market. That's 135.67% more than Johnson & Johnson (JNJ), which yields 2.16%. In dollar terms, ULTY pays $45.23/share annually versus JNJ's $5.14/share.
Dividend Growth
Over the past five years, JNJ has grown its dividend at a 5.2% CAGR compared to ULTY's -88.4%. JNJ: Dividend growth is slowing — the 3-year CAGR of 4.6% trails the 5-year rate of 5.2% and the 10-year rate of 5.6%. ULTY: Dividend growth has been steady, with a 3-year CAGR of -88.4% and a 5-year CAGR of -88.4% (10-year: -88.4%).
Dividend Safety
JNJ's dividend safety is rated "Safe." The payout ratio of 47% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 2.1x. ULTY's dividend safety is rated "Unknown." Insufficient data to assess dividend safety.
Income Comparison
A $10,000 investment in ULTY generates approximately $13783/year in dividend income, compared to $216/year from JNJ — a difference of $13567/year. At $100,000, that gap widens to $135670/year.
Verdict
- Best for income: ULTY
- Best for growth: JNJ
- Best for safety: JNJ
Frequently Asked Questions
Which has a higher dividend yield, JNJ or ULTY?
YieldMax Ultra Option Income Strategy ETF (ULTY) has a higher dividend yield of 137.83% compared to Johnson & Johnson (JNJ) at 2.16%.
Is JNJ or ULTY a better dividend growth stock?
Johnson & Johnson has the stronger dividend growth with a 5-year CAGR of 5.2%, compared to YieldMax Ultra Option Income Strategy ETF's -88.4%.
Which is safer for dividend income, JNJ or ULTY?
Johnson & Johnson's dividend safety is rated "Safe" while YieldMax Ultra Option Income Strategy ETF is rated "Unknown." The payout ratio of 47% is well within sustainable levels, leaving room for future increases. Earnings cover the dividend 2.1x.
How much income does $10,000 in JNJ vs ULTY generate?
A $10,000 investment in JNJ generates approximately $216/year in dividends, while the same amount in ULTY generates about $13783/year.
Is JNJ or ULTY a Dividend Aristocrat?
Johnson & Johnson is a Dividend King with 63 consecutive years of increases. YieldMax Ultra Option Income Strategy ETF does not currently qualify for aristocrat status.
JNJ vs ULTY: which is better for retirement income?
It depends on your priorities. ULTY for current income, JNJ for dividend growth, JNJ for safety. Many retirement investors hold both for diversification.
JNJ Dividend Analysis | ULTY Dividend Analysis | All Comparisons | Comparison Tool